The stock's fall snapped a four-day winning streak.

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Fintel reports that on October 8, 2024, Oppenheimer initiated coverage of Abbott Laboratories (NYSE:ABT) with a Outperform ...

Somerset Trust Co lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% in the 3rd quarter, ...

MedTech portfolio is growing at a CAGR (compounded annual growing rate) of 11%-13%. The company’s non-MedTech operations are ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Mattson Financial Services LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.7% in the 3rd quarter, ...

On Friday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $112.43 which represents a decrease of $-0.30 or -0.27% from the prior close of $112.73. The stock opened at $112.93 and ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE: ABT) with an Outperform rating and a price ...

Abbott Laboratories reported it achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in ...